Alexis Investment Partners’s Amgen AMGN Stock Holding History

Alexis Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31	Closed	-$10.1K	–	41
2025 Q4	$10.1K	Hold	31	–	–	﹤0.01%	71
2025 Q3	$8.75K	Buy	+31	New	+$8.99K	﹤0.01%	75

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alexis Investment Partners's AMGN Position: Q1 2026 in Review

Alexis Investment Partners sold out of Amgen (AMGN) in Q1 2026, closing a stake of 31 shares — an estimated $10.1K sold.

Alexis Investment Partners first reported a position in AMGN in Q3 2025 and held it in 2 quarters. The position peaked at $10.1K in Q4 2025. 3,138 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Alexis Investment Partners reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Alexis Investment Partners sold 31 Amgen shares in Q1 2026, an estimated $10.1K.
Alexis Investment Partners first reported a position in Amgen in Q3 2025 and held it in 2 quarters.
Alexis Investment Partners's Amgen position peaked at $10.1K in Q4 2025.
3,138 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alexis Investment Partners's 13F filing for Q1 2026, filed 24 Apr 2026.